A detailed history of Glenmede Trust CO Na transactions in Insulet Corp stock. As of the latest transaction made, Glenmede Trust CO Na holds 2,080 shares of PODD stock, worth $543,212. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,080
Previous 2,033 2.31%
Holding current value
$543,212
Previous $410,000 18.05%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$180.69 - $239.01 $8,492 - $11,233
47 Added 2.31%
2,080 $484,000
Q2 2024

Aug 14, 2024

BUY
$161.02 - $206.98 $39,610 - $50,917
246 Added 13.77%
2,033 $410,000
Q1 2024

May 15, 2024

BUY
$163.6 - $209.11 $18,814 - $24,047
115 Added 6.88%
1,787 $306,000
Q4 2023

Feb 13, 2024

BUY
$127.77 - $221.42 $213,631 - $370,214
1,672 New
1,672 $362,000
Q4 2020

Feb 16, 2021

SELL
$215.97 - $265.89 $3,455 - $4,254
-16 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$192.55 - $236.59 $1,155 - $1,419
6 Added 60.0%
16 $3,000
Q2 2020

Aug 14, 2020

SELL
$159.17 - $224.73 $4,775 - $6,741
-30 Reduced 75.0%
10 $1,000
Q4 2019

Feb 12, 2020

BUY
$144.81 - $186.0 $4,489 - $5,766
31 Added 344.44%
40 $6,000
Q3 2019

Nov 14, 2019

SELL
$117.35 - $167.95 $821 - $1,175
-7 Reduced 43.75%
9 $1,000
Q4 2018

Feb 14, 2019

BUY
$73.27 - $105.19 $1,172 - $1,683
16 New
16 $1,000
Q3 2018

Nov 15, 2018

SELL
$81.43 - $108.13 $40,715 - $54,065
-500 Closed
0 $0
Q2 2018

Nov 05, 2018

SELL
$83.27 - $101.93 $9,159 - $11,212
-110 Reduced 18.03%
500 $43,000
Q2 2018

Aug 15, 2018

BUY
$83.27 - $101.93 $41,635 - $50,965
500 Added 454.55%
610 $52,000
Q4 2017

Feb 15, 2018

BUY
$55.67 - $71.8 $3,952 - $5,097
71 Added 182.05%
110 $7,000
Q3 2017

Nov 14, 2017

BUY
$49.68 - $59.46 $1,937 - $2,318
39
39 $0

Others Institutions Holding PODD

About INSULET CORP


  • Ticker PODD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 69,403,600
  • Market Cap $18.1B
  • Description
  • Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...
More about PODD
Track This Portfolio

Track Glenmede Trust CO Na Portfolio

Follow Glenmede Trust CO Na and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

News

Stay updated on Glenmede Trust CO Na with notifications on news.